December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults ...

BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...

Boston Omaha Corporation (NYSE: BOC) (the "Company", "we", or "our") announced its financial results for the fiscal year ended December 31, 2024, in connection with filing its Annual Report on Form 10 ...

Full Year 2024 Financial Results Revenue from Continuing Operations was $20.2 million for 2024, an increase of 181% compared to $7.2 million in 2023.

Herc will finance the offer through a combination of available cash on hand, proceeds from the sale of marketable securities ...

EMERYVILLE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

TAIPEI: China has lashed out at accusations it is endangering maritime safety made by top diplomats from the Group of 7 industrialised democracies in a joint statement, saying on Saturday (Mar 15 ...

Riley Financial to Retain ~89% Ownership Stake ... stockholders of BRF's investment banking subsidiary, B. Riley Securities ("BRS"). As part of the tax-free transaction, BRS is implementing ...

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy ...